H3: code "other" was selected as the medical device remains implanted.Return not possible.H6: a review of the manufacturing records for the device verified that the lot met all pre-release specifications.H6: code d12: according to the gore® tag® conformable thoracic stent graft with active control system instructions for use (ifu), adverse events that may occur and/or require intervention include, but are not limited to: infection (e.G., aneurysm, device or access sites).W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
The following was reported to gore: on (b)(6) 2024, a gore® tag® conformable thoracic stent graft with active control system was implanted emergently in a thoracic aorta to control a bleeding from the aorta during an operation for the esophagus.On (b)(6) 2024, an infection in the vessel around the implantation area of the gore® tag® conformable thoracic stent graft with active control system was observed.The physician stated that it seemed that the gore® tag® conformable thoracic stent graft with active control system was fully expanded and it looked the endoprosthesis was outside of the aorta.So, it seemed the aorta breakdown occurred due to the infection.It is unknown whether a rupture occurred because only a simple ct was performed preoperatively.On (b)(6) 2024, a reintervention was performed.Additional gore® tag® conformable thoracic stent graft with active control system was implanted to extend the initial the gore® tag® conformable thoracic stent graft with active control system proximally and distally.The patient tolerated the procedure.The physician suggested that the infection might have occurred because the esophagus adjoined the aorta.
|